ARQ (NASDAQ:ARQ) and Bachem (OTCMKTS:BCHMF) Head-To-Head Survey
by Amy Steele · The Cerbat GemBachem (OTCMKTS:BCHMF – Get Free Report) and ARQ (NASDAQ:ARQ – Get Free Report) are both materials companies, but which is the better stock? We will compare the two companies based on the strength of their valuation, dividends, analyst recommendations, institutional ownership, earnings, risk and profitability.
Institutional and Insider Ownership
18.5% of ARQ shares are held by institutional investors. 20.1% of ARQ shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.
Analyst Recommendations
This is a breakdown of current ratings and recommmendations for Bachem and ARQ, as reported by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Bachem | 1 | 0 | 3 | 0 | 2.50 |
| ARQ | 1 | 1 | 1 | 0 | 2.00 |
ARQ has a consensus target price of $5.00, indicating a potential upside of 120.26%. Given ARQ’s higher probable upside, analysts clearly believe ARQ is more favorable than Bachem.
Profitability
This table compares Bachem and ARQ’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Bachem | N/A | N/A | N/A |
| ARQ | -42.33% | -2.48% | -1.85% |
Valuation & Earnings
This table compares Bachem and ARQ”s revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Bachem | N/A | N/A | N/A | N/A | N/A |
| ARQ | $120.34 million | 0.81 | -$52.61 million | ($1.29) | -1.76 |
Bachem has higher earnings, but lower revenue than ARQ.
Summary
Bachem beats ARQ on 5 of the 9 factors compared between the two stocks.
About Bachem
Bachem Holding AG, together with its subsidiaries, provides products for research, clinical development, and commercial application to pharmaceutical and biotechnology companies worldwide. The company engages in the development, production, and regulatory support of peptide active pharmaceutical ingredients, such as peptide and oligonucleotide new chemical entities (NCEs). It also offers commercial NCEs and generics; and project management, quality and regulatory, analytical, good manufacturing practice production, research grade production, and supply and vertical integration services. Bachem Holding AG was founded in 1971 and is headquartered in Bubendorf, Switzerland.
About ARQ
Arq, Inc. is a holding company. It engages in the provision of environmental and emission control equipment to the power generation industry. The company operates through the following Segments: Refined Coal and Advanced Purification Technologies. The Refined Coal segment includes the Tinuum Group, Tinuum Services, and GWN Manager. The Advanced Purification Technologies segment refers to the sale of Activated Carbon Injection and Dry Sorbent Injection equipment systems, chemical sales, consulting services, and other sales related to the reduction of emissions in the coal-fired electric generation process and the electric utility industry. The company was founded in 1996 and is headquartered in Greenwood Village, CO.